Literature DB >> 4834431

PMA deaths in Ontario.

G Cimbura.   

Abstract

A new street-drug, para-methoxyamphetamine (PMA), recently made its appearance in Ontario. Between March and August 1973 there were nine deaths of young people in this province that were attributed to the drug. PMA appears to have a powerful hallucinogenic effect as well as a marked toxicity to the central nervous system. The clinical picture resembles that observed in cases of acute poisoning by amphetamine and methylenedioxyamphetamine (MDA).

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4834431      PMCID: PMC1947522     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  3,4-methylenedioxyamphetamine (MDA): analytical and forensic aspects of fatal poisoning.

Authors:  G Cimbura
Journal:  J Forensic Sci       Date:  1972-04       Impact factor: 1.832

2.  Investigation of p-methoxyamphetamine excretion in amphetamine induced psychosis.

Authors:  B M Angrist; J W Schweitzer; A J Friedhoff; S Gershon
Journal:  Nature       Date:  1970-02-14       Impact factor: 49.962

3.  Structure--activity relationships of one-ring psychotomimetics.

Authors:  A T Shulgin; T Sargent; C Naranjo
Journal:  Nature       Date:  1969-02-08       Impact factor: 49.962

4.  Some new behaviour-disrupting amphetamines and their significance.

Authors:  J R Smythies; V S Johnston; R J Bradley; F Benington; R D Morin; L C Clark
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

  4 in total
  3 in total

Review 1.  Death in amphetamine users: causes and rates.

Authors:  H Kalant; O J Kalant
Journal:  Can Med Assoc J       Date:  1975-02-08       Impact factor: 8.262

Review 2.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 3.  'Designer drugs'. A problem in clinical toxicology.

Authors:  J F Buchanan; C R Brown
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.